This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA combines in-depth industry knowledge and cutting-edge analytics to evaluate issues being litigated and debated in the healthcare sector. Our industry knowledge enables us to explain, for example, the nuances of provider reimbursement or the patient incentives created by high deductible health insurance plans, and our economic, statistical, accounting, investigative, and finance skills—as well as our familiarity with key healthcare datasets—equips CRA to provide rigorous, defensible analyses tailored to the specific facts of a litigation or regulatory dispute.
Our experts have broad and deep experience in the healthcare sector including hospitals, physician practices, health insurance and health benefit plans, ACOs, PBMs, wholesalers, pharmacies, pharmaceuticals and biologicals, medical devices, clinical laboratories, dialysis facilities, ambulance transport, nursing homes, and home healthcare.
The use of digital health technologies (DHTs), ranging from devices and apps to cloud-based services and artificial intelligence platforms, has accelerated...
The Federal Trade Commission’s (FTC’s) recent announcement that it will be undertaking a retrospective study of physician group consolidations may signal an...
CRA is a proud sponsor of this event. Raphael De Coninck is a speaker during the session discussing the legal and economic highlights of the decision. For more...
Sean May is a panelist on “Viewing Hospital and Physician Mergers from Two Sides.” The session covers: Key evidence used to evaluate competitive harm from...
